Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Delcath Systems Q4 Loss Narrows

Delcath Systems Inc. (DCTH: Quote) posted fourth-quarter net loss of $15.27 million or $0.32 per share, narrower than $15.31 million or $0.36 per share in the previous year quarter.

On average, three analysts polled by Thomson Reuters expected the company to report a loss of $0.28 per share. Analysts' estimates typically exclude special items.

Operating loss for the quarter was $15.97 million, wider than $9.53 million in the comparable quarter last year.

Click here to receive FREE breaking news email alerts for Delcath Systems Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Swiss economy stalled in the second quarter as the improvement in household spending was insufficient to offset the weakness in exports and investment in construction. Gross domestic product remained flat from the first quarter, when it accelerated to 0.5 percent, the State Secretariat for Economic Affairs said Tuesday. Economists had expected GDP to rise 0.5 percent in the second quarter. Policymakers of Reserve Bank of Australia decided to maintain its record low interest rate once again as they continue to assess that the most prudent course is a period of stability in interest rates. The monetary policy board retained the cash rate at 2.50 percent. The rate has been at the current level since August 2013. A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.